Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

British Patient Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$88M
Portfolio companies 10
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Analytics
  • Artificial Intelligence
  • Compliance

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of British Patient Capital:
Typical Co-investors
British Patient Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after British Patient Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alcatel-Lucent Boulogne-Billancourt, France, Ile-de-France
Bestar Consultant Beijing, Beijing, China
Book.weibo.com -
Green D Ventures Boston, Massachusetts, United States
Guokai Ronghua -
infinitas capital Basel, Basel-Stadt, Switzerland
Ironweed Capital California, Palo Alto, United States
ITS Group Boulogne-Billancourt, France, Ile-de-France
LongLine Capital Beijing, Beijing, China
Mango V Foundation -
McConnell Venture Partners Charlotte, North Carolina, United States
McKenna Ventures Chicago, Illinois, United States
Murata Manufacturing Japan, Kyoto, Kyoto Prefecture
Oita Venture Capital Japan, Oita, Oita Prefecture
PCRS Corp California, Long Beach, United States
Refex Capital Fund Chennai, India, Tamil Nadu
Twilight Venture Partners Indiana, Indianapolis, United States
Venture Capital Action Plan -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oxford Quantum Circuits

Biotechnology
Health Care
Information and Communications Technology (ICT)
Information Technology
$52M05 Jul 2022 Oxford, Oxfordshire, United Kingdom

CloudNC

Computer
Industrial
Manufacturing
Mechanical Engineering
Software
$45M21 Jun 2022 London, England, United Kingdom

Proximie

Augmented Reality
Collaboration
Health Care
Medical
$80M14 Jun 2022 London, England, United Kingdom

IGEM Therapeutics

Biotechnology
Genetics
Therapeutics
02 Mar 2022 London, England, United Kingdom

Microbiotica

Biotechnology
Health Care
Therapeutics
$68M07 Feb 2022 Cambridge, England, United Kingdom

Thought Machine

Banking
Enterprise Software
Financial Services
FinTech
$200M29 Nov 2021 London, England, United Kingdom

Ultraleap

Consumer Electronics
Electronics
Software Engineering
Virtual Reality
$82M17 Nov 2021 Bristol, England, United Kingdom

AccuRx

Computer
Health Care
Information Technology
Internet
Software
$37M15 Sep 2021 London, England, United Kingdom

Quantexa

Analytics
Artificial Intelligence
Big Data
Compliance
$153M13 Jul 2021 London, England, United Kingdom
News
Quantexa raises $153M to build out AI-based big data tools to track risk and run investigations

– Quantexa, a London-based AI startup, raised $153m in Series D funding.
– The round was led by Warburg Pincus and joined by existing investors Dawn Capital, AlbionVC, Evolution Equity Partners (a specialist cybersecurity VC), HSBC, ABN AMRO Ventures and British Patient Capital.
– The company was valued between $800m and $900m.
– Quantexa got its start out of a gap in the market that Marria identified when he was working as a director at Ernst & Young tasked with helping its clients with money laundering and other fraudulent activity.
– It has now raised over $240m to date.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent British Patient Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: